These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 37549204)
1. Long COVID-19 Cardiac Complications Are Associated With Autoimmunity to Cardiac Self-Antigens Sufficient to Cause Cardiac Dysfunction. Cremonesi M; Felicetta A; Cannata F; Serio S; van Beek JJP; Bombace S; My I; Zanon V; Catalano C; Papadopoulou V; Monti L; Chiarito M; Stefanini G; Panico C; Francone M; Lugli E; Kallikourdis M; Condorelli G Circulation; 2023 Aug; 148(6):504-507. PubMed ID: 37549204 [No Abstract] [Full Text] [Related]
2. Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C. Burbelo PD; Castagnoli R; Shimizu C; Delmonte OM; Dobbs K; Discepolo V; Lo Vecchio A; Guarino A; Licciardi F; Ramenghi U; Rey-Jurado E; Vial C; Marseglia GL; Licari A; Montagna D; Rossi C; Montealegre Sanchez GA; Barron K; Warner BM; Chiorini JA; Espinosa Y; Noguera L; Dropulic L; Truong M; Gerstbacher D; Mató S; Kanegaye J; Tremoulet AH; ; Eisenstein EM; Su HC; Imberti L; Poli MC; Burns JC; Notarangelo LD; Cohen JI Front Immunol; 2022; 13():841126. PubMed ID: 35360001 [TBL] [Abstract][Full Text] [Related]
3. Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes. Moody R; Sonda S; Johnston FH; Smith KJ; Stephens N; McPherson M; Flanagan KL; Plebanski M Front Immunol; 2022; 13():945021. PubMed ID: 36032086 [TBL] [Abstract][Full Text] [Related]
4. Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP-Seq. Vazquez SE; Ferré EM; Scheel DW; Sunshine S; Miao B; Mandel-Brehm C; Quandt Z; Chan AY; Cheng M; German M; Lionakis M; DeRisi JL; Anderson MS Elife; 2020 May; 9():. PubMed ID: 32410729 [TBL] [Abstract][Full Text] [Related]
5. Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement. Mohkhedkar M; Venigalla SSK; Janakiraman V Mol Immunol; 2021 Sep; 137():105-113. PubMed ID: 34242919 [TBL] [Abstract][Full Text] [Related]
6. Long COVID in autoimmune rheumatic diseases. Fedorchenko Y; Zimba O Rheumatol Int; 2023 Jul; 43(7):1197-1207. PubMed ID: 36995436 [TBL] [Abstract][Full Text] [Related]
7. Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens. Ulndreaj A; Wang M; Misaghian S; Paone L; Sigal GB; Stengelin M; Campbell C; Van Nynatten LR; Soosaipillai A; Ghorbani A; Mathew A; Fraser DD; Diamandis EP; Prassas I Clin Chem Lab Med; 2022 Jun; 60(7):1116-1123. PubMed ID: 35475723 [TBL] [Abstract][Full Text] [Related]
8. Adaptive Immunity and the Risk of Autoreactivity in COVID-19. Moody R; Wilson K; Flanagan KL; Jaworowski A; Plebanski M Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445670 [TBL] [Abstract][Full Text] [Related]
9. Autoantibodies Targeting Intracellular and Extracellular Proteins in Autoimmunity. Burbelo PD; Iadarola MJ; Keller JM; Warner BM Front Immunol; 2021; 12():548469. PubMed ID: 33763057 [TBL] [Abstract][Full Text] [Related]
10. Is long COVID an autoimmune disease? Sin DD Eur Respir J; 2023 Jan; 61(1):. PubMed ID: 36634924 [No Abstract] [Full Text] [Related]
11. Case Report: Systemic Sclerosis After Covid-19 Infection. Fineschi S Front Immunol; 2021; 12():686699. PubMed ID: 34262566 [TBL] [Abstract][Full Text] [Related]
12. The crossroads between cancer immunity and autoimmunity: antibodies to self antigens. Benvenuto M; Mattera R; Masuelli L; Tresoldi I; Giganti MG; Frajese GV; Manzari V; Modesti A; Bei R Front Biosci (Landmark Ed); 2017 Mar; 22(8):1289-1329. PubMed ID: 28199204 [TBL] [Abstract][Full Text] [Related]
13. The Role of Viral Infections in the Onset of Autoimmune Diseases. Sundaresan B; Shirafkan F; Ripperger K; Rattay K Viruses; 2023 Mar; 15(3):. PubMed ID: 36992490 [TBL] [Abstract][Full Text] [Related]
14. The majority of severe COVID-19 patients develop anti-cardiac autoantibodies. Fagyas M; Nagy B; Ráduly AP; Mányiné IS; Mártha L; Erdősi G; Sipka S; Enyedi E; Szabó AÁ; Pólik Z; Kappelmayer J; Papp Z; Borbély A; Szabó T; Balla J; Balla G; Bai P; Bácsi A; Tóth A Geroscience; 2022 Oct; 44(5):2347-2360. PubMed ID: 36112333 [TBL] [Abstract][Full Text] [Related]
15. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease. Manns MP; Obermayer-Straub P Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334 [TBL] [Abstract][Full Text] [Related]
16. Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection. Chen C; Amelia A; Ashdown GW; Mueller I; Coussens AK; Eriksson EM Mol Med; 2021 Dec; 27(1):160. PubMed ID: 34930107 [TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to intracellular autoantigens and their B-cell epitopes: molecular probes to study the autoimmune response. Routsias JG; Vlachoyiannopoulos PG; Tzioufas AG Crit Rev Clin Lab Sci; 2006; 43(3):203-48. PubMed ID: 16574554 [TBL] [Abstract][Full Text] [Related]
18. The recognition of self-antigens and autoimmune disease. Smith SC; Allen PM Curr Opin Immunol; 1991 Feb; 3(1):22-5. PubMed ID: 2054110 [TBL] [Abstract][Full Text] [Related]